Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In the US, cash-paying patients have a 12-month persistence rate of 13%, while insured individuals see rates of 36% 4
Retatrutide is a medication still in clinical trials that might surpass these popular medications in weight-loss effectiveness
Prior authorization is required for most biologics and GLP-1 agents administered under this code, and the MAC's LCD governs coverage for the specific drug
Apotex submission clears review The second authorization went to a submission filed by Canadian-based Apotex, a generic version of the brand-name drug Ozempic
US$ 20.46
US$ 21.59
US$ 20.74
